Skip to main content

Advertisement

Log in

DCD donations and outcomes of heart transplantation: the Australian experience

  • Review Article
  • Published:
Indian Journal of Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Purpose

There is increasing clinical utilization of hearts from the donation after circulatory death (DCD) pathway with the aim of expanding the donor pool and mitigating the ever-present discrepancy between the inadequate availability of good quality donor hearts and the rising number of patients with end-stage heart failure.

Methods

This article reviews the rationale, practice, logistical factors, and 5-year experience of DCD heart transplantation at St Vincent’s Hospital, Sydney.

Findings

Between July 2014 and July 2019, 69 DCD donor retrievals were undertaken resulting in 49 hearts being instrumented on an ex situ normothermic cardiac perfusion device. Seventeen (35%) of these hearts were declined and the remaining 32 (65%) were used for orthotopic DCD heart transplantation. At 5 years of follow-up, the 1-, 3-, and 5-year survival was 96%, 94%, and 94% for DCD hearts compared with 89%, 83%, and 82% respectively for donation after brain death (DBD) hearts (n.s). The immediate post-implant requirement for temporary extra-corporeal membrane oxygenation (ECMO) support for delayed graft function was 31% with no difference in rejection rates when compared with the contemporaneous cohort of patients transplanted with standard criteria DBD hearts.

Summary

DCD heart transplantation has become routine and incorporated into standard clinical practice by a handful of pioneering clinical transplant centres. The Australian experience demonstrates that excellent medium-term outcomes are achievable from the use of DCD hearts. These outcomes are consistent across the other centres and consequently favour a more rapid and wider uptake of heart transplantation using DCD donor hearts, which would otherwise be discarded.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Dhital KK, Iyer A, Connellan M, et al. Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series. Lancet. 2015;385:2585–91.

    Article  Google Scholar 

  2. Barnard CN. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J. 1967;41:1271–4.

    CAS  PubMed  Google Scholar 

  3. Boucek MM, Mashburn C, Dunn SM, et al. Pediatric heart transplantation after declaration of cardiocirculatory death. N Engl J Med. 2008;359:709–14.

    Article  CAS  Google Scholar 

  4. Kleinmahon JA, Patel SS, Auerbach SR, et al. Hearts transplanted after circulatory death in children: Analysis of the International Society for Heart and Lung Transplantation registry. Pediatr Transplant. 2017;21:e13064.

    Article  Google Scholar 

  5. Messer S, Large S. Resuscitating heart transplantation: the donation after circulatory determined death donor. Eur J Cardiothorac Surg. 2016;49:1–4.

    Article  Google Scholar 

  6. Garcia Saez D, Bowles CT, Mohite PN, et al. Heart transplantation after donor circulatory death in patients bridged to transplant with implantable left ventricular assist devices. J Heart Lung Transplant. 2016;35:1255–60.

    Article  Google Scholar 

  7. Mehta V, Taylor M, Hasan J, et al. Establishing a heart transplant programme using donation after circulatory-determined death donors: a United Kingdom based single-centre experience. Interact Cardiovasc Thorac Surg. 2019;29:422–9.

    Article  Google Scholar 

  8. http://www.newcastle-hospitals.org.uk/news/news-item-23933.aspx.

  9. https://surgery.duke.edu/news/doctors-duke-university-hospital-perform-first-dcd-heart-transplant-us.

  10. https://www.massgeneral.org/news/press-release/Massachusetts-general-hospital-performs-first-of-its-kind-heart-transplant-in-new-england.

  11. https://www.surgery.wisc.edu/2020/01/10/division-of-cardiothoracic-surgery-makes-uw-hospital-the-third-center-in-the-u-s-to-perform-a-donation-after-circulatory-death-dcd-heart-transplant/.

  12. Messer S, Page A, Colah S, et al. Human heart transplantation from donation after circulatory- determined death donors using normothermic regional perfusion and cold storage. J Heart Lung Transplant. 2018;37:865–9.

    Article  Google Scholar 

  13. Kushnood A, Butt TA, Jungschleger J, et al. Paediatric donation after circulatory determined death heart transplantation using donor normothermic regional perfusion and ex situ heart perfusion: A case report. Pediatr Transplant. 2019;23:e13536.

    Google Scholar 

  14. Tchana-Sato V, Ledoux D, Detry O, et al. Successful clinical transplantation of hearts donated after circulatory death using normothermic regional perfusion. J Heart Lung Transplant. 2019;38:593–8.

    Article  Google Scholar 

  15. Tchana-Sato V, Ledoux D, Vandendriessche K, et al. First report of successful pediatric heart transplantation from donation after circulatory death with distant procurement using normothermic regional perfusion and cold storage. J Heart Lung Transplant. 2019;38:1112–5.

    Article  Google Scholar 

  16. Lomero M, Gardiner D, Coli E, et al. Donation after circulatory death today: an updated overview of the European landscape. Transpl Int. 2020;33:76–88.

    Article  Google Scholar 

  17. Thuong M, Ruiz A, Evrard P, et al. New classification of donation after circulatory death donors definitions and terminology. Transpl Int. 2016;29:749–59.

    Article  Google Scholar 

  18. Bollen JAM, Shaw D, de Wert G, et al. Euthanasia through living organ donation: ethical, legal, and medical challenges. J Heart Lung Transplant. 2019;38:111–3.

    Article  Google Scholar 

  19. Watson A, Gao L, Sun L, et al. Enhanced preservation of pig cardiac allografts by combining erythropoietin with glyceryl trinitrate and zoniporide. Am J Transplant. 2013;13:1676–87.

    Article  CAS  Google Scholar 

  20. Iyer A, Gao L, Doyle A, et al. Increasing the tolerance of DCD hearts to warm ischemia by pharmacological postconditioning. Am J Transplant. 2014;14:1744–52.

    Article  CAS  Google Scholar 

  21. Iyer A, Gao L, Doyle A, et al. Normothermic ex vivo perfusion provides superior organ preservation and enables viability assessment of hearts from DCD donors. Am J Transplant. 2015;15:371–80.

    Article  CAS  Google Scholar 

  22. Iyer A, Chew HC, Gao L, et al. Pathophysiological trends during withdrawal of life support: implications for organ donation after circulatory death. Transplantation. 2016;100:2621–9.

    Article  Google Scholar 

  23. Iyer A, Wan B, Kumarasinghe G, et al. What is the potential source of heart allografts from donation after circulatory death (DCD) donors? Transplantation. 2013;96:S217.

    Article  Google Scholar 

  24. Listijono DR, Watson A, Pye R, et al. Usefulness of extracorporeal membrane oxygenation for early cardiac allograft dysfunction. J Heart Lung Transplant. 2011;30:783–9.

    Article  Google Scholar 

  25. https://donatelife.gov.au/sites/default/files/Brain_Death_Determination_Statement.pdf.

  26. Cao Y, Shahrestani S, Chew H, et al. Donation after circulatory death for liver transplantation: A meta-analysis on the location of life support withdrawal affecting outcomes. Transplantation. 2016;100:1513–24.

    Article  CAS  Google Scholar 

  27. Connellan M, Dhital K. Donor heart procurement from the donation after circulatory death pathway. Oper Tech Thorac Cardiovasc Surg. 2017;22:58–67.

    Article  Google Scholar 

  28. Chew HC, Iyer A, Connellan M, et al. Outcomes of donation after circulatory death heart transplantation in Australia. J Am Coll Cardiol. 2019;73:1447–59.

    Article  Google Scholar 

  29. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischaemic preconditioning. AM J Physiol Heart Circ Physiol. 2003;285:H579–88.

    Article  CAS  Google Scholar 

  30. Hausenloy DJ, Barrabes JA, Botker HE, et al. Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res Cardiol. 2016;111:70.

    Article  Google Scholar 

  31. Gao L, Hicks M, Macdonald PS. Improved preservation of the rat heart with Celsior solution supplemented with cariporide plus glyceryl trinitrite. Am J Transplant. 2005;5:1820–6.

    Article  CAS  Google Scholar 

  32. Hing AJ, Watson A, Hicks M, et al. Combining cariporide with glyceryl trinitrite optimizes cardiac preservation during porcine heart transplantation. Am J Transplant. 2009;9:2048–56.

    Article  CAS  Google Scholar 

  33. Gao L, Tsun J, Sun L, et al. Critical role of the STAT 3 pathway in the cardioprotective efficacy of zoniporide in a model of myocardial preservation- The rat isolated working heart. Br J Pharmacol. 2011;162:633–47.

    Article  CAS  Google Scholar 

  34. Watson AJ, Gao L, Sun L, et al. Enhanced preservation of the rat heart after prolonged hypothermic ischaemia with erythropoietin supplemented Celsior solution. J Heart Lung Transplant. 2013;32:633–40.

    Article  Google Scholar 

  35. Ardehali A, Esmailian F, Deng M, et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomized, non-inferiority trial. Lancet. 2015;385:2577–84.

    Article  Google Scholar 

  36. Messer S, Ardehali A, Tsui S. Normothermic donor heart perfusion: current clinical experience and the future. Transpl Int. 2015;28:634–42.

    Article  Google Scholar 

  37. Garcia Saez D, Zych B, Sabashnikov A, et al. Evaluation of the organ care system in heart transplantation with adverse donor/recipient profile. Ann Thorac Surg. 2014;98:2099–105.

    Article  Google Scholar 

  38. Connellan M, Chew H, Iyer A, et al. Ex-vivo perfusion of marginal donor hearts: is normal allograft function assured post-transplant? J Heart Lung Transplant. 2019;25:e92.

    Article  Google Scholar 

  39. Sponga S, Ferrara V, Beltrami AP, et al. Ex-vivo perfusion on marginal donors in heart transplantation: Clinical results and pathological findings. J Heart Lung Transplant. 2019;38:s42–3.

    Article  Google Scholar 

  40. Schroder JN, D’Alessandro D, Esmailian F, et al. Successful utilization of extended criteria donor (ECD) hearts for transplantation – results of the OCS heart EXPAND trial to evaluate the effectiveness and safety of the OCS heart system to preserve and assess ECD hearts for transplantation. J Heart Lung Transplant. 2019;38:s42.

    Article  Google Scholar 

  41. Messer S, Page A, Axell R, et al. Outcome after heart transplantation from donation after circulatory-determined death donors. J Heart Lung Transplant. 2017;36:1311–8.

    Article  Google Scholar 

  42. Anthony C, Michel J, Christofi M, et al. Ex vivo coronary angiographic evaluation of a beating donor heart. Circulation. 2014;130:e341–3.

    Article  Google Scholar 

  43. No authors listed. A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to examine the definition of brain death. JAMA. 1968;205:337–40.

    Article  Google Scholar 

  44. Machando C, Korein J, Ferrer Y, et al. The declaration of Sydney on human death. J Med Ethics. 2007;33:699–703.

    Article  Google Scholar 

  45. Steen S, Paskevicius A, Liao Q, Sjoberg T. Safe orthotopic transplantation of hearts harvested 24 hours after brain death and preserved for 24 hours. Scand Cardiovasc J. 2016;50:193–200.

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Dr. Helen Opdam, the National Medical Director of the Australian Organ & Tissue Authority, for collating information of the use of ante mortem heparin in the various Australian states.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kumud Dhital.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dhital, K., Ludhani, P., Scheuer, S. et al. DCD donations and outcomes of heart transplantation: the Australian experience. Indian J Thorac Cardiovasc Surg 36 (Suppl 2), 224–232 (2020). https://doi.org/10.1007/s12055-020-00998-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12055-020-00998-x

Keywords

Navigation